Cargando…

sTREM-1 is a specific biomarker of TREM-1 pathway activation

Detalles Bibliográficos
Autores principales:	Jolly, Lucie, Carrasco, Kévin, Salcedo-Magguilli, Margarita, Garaud, Jean-Jacques, Lambden, Simon, van der Poll, Tom, Mebazaa, Alexandre, Laterre, Pierre-François, Gibot, Sebastien, Boufenzer, Amir, Derive, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322270/ https://www.ncbi.nlm.nih.gov/pubmed/34282296 http://dx.doi.org/10.1038/s41423-021-00733-5

Ejemplares similares

Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis
por: Boufenzer, Amir, et al.
Publicado: (2021)

Urine sTREM-1 assessment in diagnosing sepsis and sepsis-related acute kidney injury
por: Derive, Marc, et al.
Publicado: (2011)

Role of TREM-1 in endothelial dysfunction during experimental sepsis
por: Boufenzer, A, et al.
Publicado: (2012)

Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19
por: de Nooijer, Aline H., et al.
Publicado: (2021)

Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial
por: François, Bruno, et al.
Publicado: (2023)

Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
por: Hok-A-Hin, Yanaika S., et al.
Publicado: (2023)

Effects of a TREM-like transcript-1 derived peptide during septic shock in pigs
por: Gibot, S, et al.
Publicado: (2012)

Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation
por: Gibot, Sébastien, et al.
Publicado: (2019)

Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial
por: Francois, Bruno, et al.
Publicado: (2021)

TREM-1 SNP rs2234246 regulates TREM-1 protein and mRNA levels and is associated with plasma levels of L-selectin
por: Aldasoro Arguinano, Alex-Ander, et al.
Publicado: (2017)

Leishmania infantum Induces the Release of sTREM-1 in Visceral Leishmaniasis
por: Bomfim, Lays G. S., et al.
Publicado: (2017)

Dynamic Monitoring of sTREM-1 and Other Biomarkers in Acute Cholangitis
por: Jiang, Jiahui, et al.
Publicado: (2020)

The sTREM2 Concentrations in the Blood: A Marker of Neurodegeneration?
por: Ferri, Evelyn, et al.
Publicado: (2021)

sTREM-1 as a Prognostic Marker of Postoperative Complications in Cardiac Surgery
por: Golovkin, A. S., et al.
Publicado: (2012)

Diagnostic value of sTREM-1 and procalcitonin levels in the early diagnosis of sepsis
por: Aksaray, Sebahat, et al.
Publicado: (2017)

Soluble TREM-1 plasma concentration predicts poor outcome in COVID-19 patients
por: Gibot, Sébastien, et al.
Publicado: (2023)

Association of decreased serum sTREM-1 level with the severity of coronary artery disease: Inhibitory effect of sTREM-1 on TNF-α- and oxLDL-induced inflammatory reactions in endothelial cells
por: Dai, Daopeng, et al.
Publicado: (2016)

Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis
por: Azzolini, Federica, et al.
Publicado: (2022)

Diagnostic and Prognostic Value of IL-6 and sTREM-1 in SIRS and Sepsis in Children
por: Smok, Beata, et al.
Publicado: (2020)

sTREM-1 and TNF-α levels are associated with the clinical outcome of leprosy patients
por: Bezerra-Santos, Márcio, et al.
Publicado: (2023)

Role of sTREM-1 in predicting mortality of infection: a systematic review and meta-analysis
por: Su, Longxiang, et al.
Publicado: (2016)

Evaluation of sTREM1 and suPAR Biomarkers as Diagnostic and Prognostic Predictors in Sepsis Patients
por: Nasr El-Din, Asmaa, et al.
Publicado: (2021)

Validation of sTREM-1 and IL-6 based algorithms for outcome prediction of COVID-19
por: Van Singer, Mathias, et al.
Publicado: (2023)

Soluble TLT-1 is a naturally occurring TREM-1 inhibitor and protects mice from hyperresponsiveness and death during sepsis
por: Derive, M, et al.
Publicado: (2010)

CSF sTREM2: marking the tipping point between preclinical AD and dementia?
por: Schindler, Suzanne E, et al.
Publicado: (2016)

Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
por: Ma, Ling-Zhi, et al.
Publicado: (2020)

Plasma sTREM2: a potential marker of cerebrovascular injury in neurodegenerative disorders
por: Rodriguez-Vieitez, Elena, et al.
Publicado: (2021)

sTREM-1 is not suitable to discriminate survivors and nonsurvivors in surgical patients with severe sepsis or septic shock
por: Bopp, C, et al.
Publicado: (2007)

Correction: Role of sTREM-1 in predicting mortality of infection: a systematic review and meta-analysis
Publicado: (2016)

COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department
por: Van Singer, Mathias, et al.
Publicado: (2021)

sTREM-1 predicts mortality in hospitalized patients with infection in a tropical, middle-income country
por: Wright, Shelton W., et al.
Publicado: (2020)

Serum sTREM-1 and CXCL-16 Levels in Children with Mycoplasma pneumoniae Pneumonia and Their Diagnostic Value
por: Fang, Chengchao, et al.
Publicado: (2021)

Circulating sTREM-1 as a predictive biomarker of pediatric multisystemic inflammatory syndrome (MIS-C)
por: Gonçalves, Guilherme S., et al.
Publicado: (2023)

Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
por: Wei, Yongjun, et al.
Publicado: (2023)

Diagnostic value of urine sTREM-1 for sepsis and relevant acute kidney injuries: a prospective study
por: Su, Long-xiang, et al.
Publicado: (2011)

Cerebrospinal fluid sTREM2 in Alzheimer’s disease: comparisons between clinical presentation and AT classification
por: Knapskog, Anne-Brita, et al.
Publicado: (2020)

CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study
por: Dong, Ming-Hao, et al.
Publicado: (2022)

sTREM2 is a plasma biomarker for human NASH and promotes hepatocyte lipid accumulation
por: Kothari, Vishal, et al.
Publicado: (2023)

sTREM2 is associated with attenuated tau aggregate accumulation in the presence of amyloid-β pathology
por: Nabizadeh, Fardin
Publicado: (2023)

Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?
por: Roe, Kelsey, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lnqk09tp4vna183cgsnobl83c3